Published in J Neurovirol on June 01, 2001
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol (2005) 1.68
Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology (2009) 1.17
Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. J Virol (2011) 1.09
Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment. J Neurovirol (2011) 0.89
Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review. Am J Infect Dis (2009) 0.86
Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation. J Neuroimmune Pharmacol (2010) 0.85
Impact of Tat Genetic Variation on HIV-1 Disease. Adv Virol (2012) 0.85
HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research. J Neurovirol (2014) 0.84
CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection. Future Microbiol (2009) 0.82
Genetic variation and HIV-associated neurologic disease. Adv Virus Res (2013) 0.81
Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I. Virol J (2014) 0.80
Early emergence and selection of a SIV-LTR C/EBP site variant in SIV-infected macaques that increases virus infectivity. PLoS One (2012) 0.79
HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity. PLoS One (2016) 0.79
Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences. PLoS One (2014) 0.78
Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development. J Gen Virol (2012) 0.77
Impact of viral activators and epigenetic regulators on HIV-1 LTRs containing naturally occurring single nucleotide polymorphisms. Biomed Res Int (2015) 0.77
Genotypic and phenotypic heterogeneity in the U3R region of HIV type 1 subtype C. AIDS Res Hum Retroviruses (2013) 0.75
A polytropic caprine arthritis encephalitis virus promoter isolated from multiple tissues from a sheep with multisystemic lentivirus-associated inflammatory disease. Viruses (2013) 0.75
The role of mononuclear phagocytes in HTLV-III/LAV infection. Science (1986) 17.33
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature (1997) 5.45
Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology (2011) 4.63
Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol (1995) 3.78
The incidence of ocular metastatic carcinoma. Arch Ophthalmol (1971) 3.64
HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology (2001) 3.55
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.21
HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 3.17
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 3.17
Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology (2007) 3.14
Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J Virol (1990) 2.93
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci U S A (1998) 2.89
Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA (1986) 2.86
CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol (1989) 2.77
Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet (1991) 2.60
Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol (1992) 2.52
Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology (1999) 2.52
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology (1999) 2.49
Clinical-neuropathologic correlation in HIV-associated dementia. Neurology (1993) 2.47
Education research: neurology residency training in the new millennium. Neurology (2009) 2.22
Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol (1996) 2.22
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology (2004) 2.18
Isolation of a type C RNA virus from an established human histiocytic lymphoma cell line. Proc Natl Acad Sci U S A (1977) 2.18
Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS) Neurology (1990) 2.17
Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology (2002) 2.17
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology (1997) 2.15
Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol (1993) 2.09
Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides. J Exp Med (1988) 2.08
HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology (2006) 2.06
Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol (1998) 2.05
Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol (1987) 2.05
Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science (1988) 1.97
Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology (1995) 1.95
Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology (1988) 1.94
Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology (1999) 1.93
Multiple myeloma and its ocular manifestations. Surv Ophthalmol (1987) 1.92
Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes. Antimicrob Agents Chemother (2000) 1.92
Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology (1994) 1.88
Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A (1980) 1.86
Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol (2004) 1.78
Isolation of HIV-1 from monocytes but not T lymphocytes. Lancet (1987) 1.77
Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science (1996) 1.76
Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol (1993) 1.73
Biomarkers of HIV-1 CNS infection and injury. Neurology (2007) 1.69
Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology (1993) 1.68
Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia. Neurology (2004) 1.66
Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology (2007) 1.62
Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort Study. Percept Mot Skills (1991) 1.62
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol (2012) 1.60
Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology (1993) 1.59
Neovascularization of the iris (rubeosis iridis). Surv Ophthalmol (1978) 1.59
Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol (2000) 1.58
Variable progression of HIV-associated dementia. Neurology (1998) 1.54
Persistence of infectious HIV on follicular dendritic cells. J Immunol (2001) 1.54
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc (2011) 1.53
Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol (1998) 1.52
Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate. Antiviral Res (1999) 1.51
Associations between retinal nerve fiber layer abnormalities and optic nerve examination. Neurology (2010) 1.49
Survey of training programs' means for promoting neurology and attracting trainees. Neurology (2006) 1.49
Progressive multifocal leukoencephalopathy in a patient without immunodeficiency. Neurology (2011) 1.48
Impaired reinnervation in HIV infection following experimental denervation. Neurology (2007) 1.47
Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology (2006) 1.47
Heavy metal concentrations in surface sediments in a nearshore environment, Jurujuba Sound, Southeast Brazil. Environ Pollut (2000) 1.47
Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology (1999) 1.46
Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology (2000) 1.45
Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS. Neurology (1993) 1.45
Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV. Neurology (1997) 1.45
Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology (2006) 1.45
HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst (2001) 1.45
Fulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users. Neurology (2011) 1.44
Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology (2003) 1.44
Asymptomatic HIV infection does not cause EEG abnormalities: results from the Multicenter AIDS Cohort Study (MACS) Neurology (1992) 1.43
Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol (1999) 1.42
The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology (2006) 1.42
Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J Virol (1999) 1.40
Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. AJNR Am J Neuroradiol (2000) 1.40
Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med (2007) 1.40
Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol (1998) 1.39
Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry (1995) 1.38
Drusen of the optic disc. A retrospective study in cadaver eyes. Br J Ophthalmol (1975) 1.38
Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann Neurol (2001) 1.37
A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses. Antimicrob Agents Chemother (1999) 1.35
Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology (2002) 1.35
Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol (1994) 1.34
"Sternberg-reed" giant cells of Hodgkin's Disease: cultivation in vitro, heterotransplantation, and characterization as neoplastic macrophages. Int J Cancer (1977) 1.34
HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol (1989) 1.34
Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. J Virol (1998) 1.30
Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS (2000) 1.30
Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence. Curr Top Microbiol Immunol (1995) 1.29
The neurobiology of human immunodeficiency virus infections. FASEB J (1988) 1.29
Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology (1997) 1.27
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect (2005) 1.27
A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology (1998) 1.27
Langerhans' cells are an actual site of HIV-1 replication. Intervirology (1988) 1.27
Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol (1996) 1.26
Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology (2005) 1.25